AAAAAA
Results: 1-25/26
Authors:
Colussi, C
Fiumicino, S
Giuliani, A
Rosini, S
Musiani, P
Macri, C
Potten, CS
Crescenzi, M
Bignami, M
Citation: C. Colussi et al., 1,2-dimethylhydrazine-induced colon carcinoma and lymphoma in msh2(-/-) mice, J NAT CANC, 93(20), 2001, pp. 1534-1540
Authors:
Di Carlo, E
Rovero, S
Boggio, K
Quaglino, E
Amici, A
Smorlesi, A
Forni, G
Musiani, P
Citation: E. Di Carlo et al., Inhibition of mammary carcinogenesis by systemic interleukin 12 or p185(neu) DNA vaccination in Her-2/neu transgenic BALB/c mice, CLIN CANC R, 7(3), 2001, pp. 830S-837S
Authors:
Alonzi, T
Middleton, G
Wyatt, S
Buchman, V
Betz, UAK
Muller, W
Musiani, P
Poli, V
Davies, AM
Citation: T. Alonzi et al., Role of STAT3 and Pl 3-Kinase/Akt in mediating the survival actions of cytokines on sensory neurons, MOL CELL NE, 18(3), 2001, pp. 270-282
Authors:
Rovero, S
Boggio, K
Di Carlo, E
Amici, A
Quaglino, E
Porcedda, P
Musiani, P
Forni, G
Citation: S. Rovero et al., Insertion of the DNA for the 163-171 peptide of IL1 beta enables a DNA vaccine encoding p185(neu) to inhibit mammary carcinogenesis in Heu-2/neu transgenic BALB/c mice, GENE THER, 8(6), 2001, pp. 447-452
Authors:
Pupa, SM
Invernizzi, AM
Forti, S
Di Carlo, E
Musiani, P
Nanni, P
Lollini, PL
Meazza, R
Ferrini, S
Menard, S
Citation: Sm. Pupa et al., Prevention of spontaneous neu-expressing mammary tumor development in micetransgenic for rat proto-neu by DNA vaccination, GENE THER, 8(1), 2001, pp. 75-79
Authors:
Nanni, P
Nicoletti, G
De Giovanni, C
Landuzzi, L
Di Carlo, E
Cavallo, F
Pupa, SM
Rossi, I
Colombo, MP
Ricci, C
Astolfi, A
Musiani, P
Forni, G
Lollini, PL
Citation: P. Nanni et al., Combined allogeneic tumor cell vaccination and systemic interleukin 12 prevents mammary carcinogenesis in HER-2/neu transgenic mice, J EXP MED, 194(9), 2001, pp. 1195-1205
Authors:
Cavallo, F
Quaglino, E
Cifaldi, L
Di Carlo, E
Andre, A
Bernabei, P
Musiani, P
Forni, G
Calogero, RA
Citation: F. Cavallo et al., Interleukin 12-activated lymphocytes influence tumor genetic programs, CANCER RES, 61(8), 2001, pp. 3518-3523
Authors:
Cifaldi, L
Quaglino, E
Di Carlo, E
Musiani, P
Spadaro, M
Lollini, PL
Wolf, S
Boggio, K
Forni, G
Cavallo, F
Citation: L. Cifaldi et al., A light, nontoxic interleukin 12 protocol inhibits HER-2/neu mammary carcinogenesis in BALB/c transgenic mice with established hyperplasia, CANCER RES, 61(7), 2001, pp. 2809-2812
Authors:
Di Carlo, E
Forni, G
Lollini, P
Colombo, MP
Modesti, A
Musiani, P
Citation: E. Di Carlo et al., The intriguing role of polymorphonuclear neutrophils in antitumor reactions, BLOOD, 97(2), 2001, pp. 339-345
Authors:
Gaggero, A
Comes, A
Meazza, R
Di Carlo, E
Musiani, P
Azzarone, B
Ferrini, S
Citation: A. Gaggero et al., Different biological role and anti-tumor activity of interleukin-15 isoforms, EUR CYTOKIN, 11(3), 2000, pp. 517-518
Authors:
Bossi, G
Scardigli, R
Musiani, P
Martinelli, R
Gentileschi, MP
Soddu, S
Sacchi, A
Citation: G. Bossi et al., Development of a murine orthotopic model of leukemia: Evaluation of TP53 gene therapy efficacy, CANC GENE T, 7(1), 2000, pp. 135-143
Authors:
Brunetti, M
Martelli, N
Manarini, S
Mascetra, N
Musiani, P
Cerletti, C
Aiello, FB
Evangelista, V
Citation: M. Brunetti et al., Polymorphonuclear leukocyte apoptosis is inhibited by platelet-released mediators, role of TGF beta-1, THROMB HAEM, 84(3), 2000, pp. 478-483
Authors:
Di Carlo, E
Meazza, R
Basso, S
Rosso, O
Comes, A
Gaggero, A
Musiani, P
Santi, L
Ferrini, S
Citation: E. Di Carlo et al., Dissimilar anti-tumour reactions induced by tumour cells engineered with the interleukin-2 or interleukin-15 gene in nude mice, J PATHOLOGY, 191(2), 2000, pp. 193-201
Authors:
Rovero, S
Amici, A
Di Carlo, E
Bei, R
Nanni, P
Quaglino, E
Porcedda, P
Boggio, K
Smorlesi, A
Lollini, PL
Landuzzi, L
Colombo, MP
Giovarelli, M
Musiani, P
Forni, G
Citation: S. Rovero et al., DNA vaccination against rat Her-2/neu p185 more effectively inhibits carcinogenesis than transplantable carcinomas in transgenic BALB/c mice, J IMMUNOL, 165(9), 2000, pp. 5133-5142
Authors:
Di Carlo, E
Comes, A
Basso, S
De Ambrosis, A
Meazza, R
Musiani, P
Moelling, K
Albini, A
Ferrini, S
Citation: E. Di Carlo et al., The combined action of IL-15 and IL-12 gene transfer can induce tumor cellrejection without T and NK cell involvement, J IMMUNOL, 165(6), 2000, pp. 3111-3118
Authors:
Giovarelli, M
Cappello, P
Forni, G
Salcedo, T
Moore, PA
LeFleur, DW
Nardelli, B
Di Carlo, E
Lollini, PL
Ruben, S
Ullrich, S
Garotta, G
Musiani, P
Citation: M. Giovarelli et al., Tumor rejection and immune memory elicited by locally released LEC chemokine are associated with an impressive recruitment of APCs, lymphocytes, and granulocytes, J IMMUNOL, 164(6), 2000, pp. 3200-3206
Authors:
Diodoro, MG
Di Carlo, E
Zappacosta, R
Iezzi, M
Coletti, A
Modesti, A
D'Antuono, T
Forni, G
Musiani, P
Citation: Mg. Diodoro et al., Salivary carcinoma in HER-2/neu transgenic male mice: An angiogenic switchis not required for tumor onset and progression, INT J CANC, 88(3), 2000, pp. 329-335
Authors:
Meazza, R
Lollini, PL
Nanni, P
De Giovanni, C
Gaggero, A
Comes, A
Cilli, M
Di Carlo, E
Ferrini, S
Musiani, P
Citation: R. Meazza et al., Gene transfer of a secretable form of IL-15 in murine adenocarcinoma cells: Effects on tumorigenicity, metastatic potential and immune response, INT J CANC, 87(4), 2000, pp. 574-581
Authors:
Nanni, P
Pupa, SM
Nicoletti, G
De Giovanni, C
Landuzzi, L
Rossi, I
Astolfi, A
Ricci, C
De Vecchi, R
Invernizzi, AM
Di Carlo, E
Musiani, P
Forni, G
Menard, S
Lollini, PL
Citation: P. Nanni et al., p185(neu) protein is required for tumor and anchorage-independent growth, not for cell proliferation of transgenic mammary carcinoma, INT J CANC, 87(2), 2000, pp. 186-194
Authors:
Boggio, K
Di Carlo, E
Rovero, S
Cavallo, F
Quaglino, E
Lollini, PL
Nanni, P
Nicoletti, G
Wolf, S
Musiani, P
Forni, G
Citation: K. Boggio et al., Ability of systemic interleukin-12 to hamper progressive stages of mammarycarcinogenesis in HER2/neu transgenic mice, CANCER RES, 60(2), 2000, pp. 359-364
Authors:
Forni, G
Lollini, PL
Musiani, P
Colombo, MP
Citation: G. Forni et al., Immunoprevention of cancer: Is the time ripe?, CANCER RES, 60(10), 2000, pp. 2571-2575
Authors:
Di Carlo, E
Diodoro, MG
Boggio, K
Modesti, A
Modesti, M
Nanni, P
Forni, G
Musiani, P
Citation: E. Di Carlo et al., Analysis of mammary carcinoma onset and progression in HER-2/neu oncogene transgenic mice reveals a lobular origin, LAB INV, 79(10), 1999, pp. 1261-1269
Authors:
Giovarelli, M
Musiani, P
Garotta, G
Ebner, R
Di Carlo, E
Kim, Y
Cappello, P
Rigamonti, L
Bernabei, P
Novelli, F
Modesti, A
Coletti, A
Ferrie, AK
Lollini, PL
Ruben, S
Salcedo, T
Forni, G
Citation: M. Giovarelli et al., A "stealth effect": Adenocarcinoma cells engineered to express TRAIL eludetumor-specific and allogeneic T cell reactions, J IMMUNOL, 163(9), 1999, pp. 4886-4893
Authors:
Cavallo, F
Di Carlo, E
Butera, M
Verrua, R
Colombo, MP
Musiani, P
Forni, G
Citation: F. Cavallo et al., Immune events associated with the cure of established tumors and spontaneous metastases by local and systemic interleukin 12, CANCER RES, 59(2), 1999, pp. 414-421
Authors:
Rozera, C
Carlei, D
Lollini, PL
De Giovanni, C
Musiani, P
Di Carlo, E
Belardelli, F
Ferrantini, M
Citation: C. Rozera et al., Interferon (IFN)-beta gene transfer into TS/A adenocarcinoma cells and comparison with IFN-alpha - Differential effects on tumorigenicity and host response, AM J PATH, 154(4), 1999, pp. 1211-1222